Altre lingue Cytokinetics, Incorporated

Azioni

CYTK

US23282W6057

Tempo reale stimato Cboe BZX Altri mercati azionari 17:25:49 26/04/2024			Variaz. 5gg	Var. 1 gen.
65,36 ^USD	+0,87%		-2,81%	-21,37%

09/04	L'insider di Cytokinetics ha venduto azioni per un valore di 2.422.918 dollari, secondo un recente deposito SEC	MT
05/04	Aggiornamento settoriale: i titoli del settore sanitario salgono venerdì pomeriggio	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Cytokinetics to Announce First Quarter Results on May 8, 2024	24/04
Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress	10/04
Cytokinetics Insider Sold Shares Worth $2,422,918, According to a Recent SEC Filing	09/04
Sector Update: Health Care Stocks Rise Friday Afternoon	05/04
Cytokinetics Reports Positive Follow-On Data for Prospective Heart Medication; Shares Rise	05/04
Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Session	05/04
Cytokinetics Presents Additional 48-Week Data from Forest-Hcm, the Open Label Extension Clinical Study of Aficamten, At the American College of Cardiology 73rd Annual Scientific Session	05/04
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	02/04
Cytokinetics to Participate in the 23rd Annual Needham Virtual Healthcare Conference	01/04
Cytokinetics Announces Four Upcoming Presentations at the American College of Cardiology 73rd Annual Scientific Session	25/03
Cytokinetics, Incorporated(NasdaqGS:CYTK) added to S&P 400 - Biotechnology	18/03
Cytokinetics, Incorporated(NasdaqGS:CYTK) added to S&P 400 Health Care	18/03
Cytokinetics, Incorporated(NasdaqGS:CYTK) added to S&P 400	18/03
Cytokinetics, Incorporated(NasdaqGS:CYTK) dropped from S&P 600	18/03
Cytokinetics, Incorporated(NasdaqGS:CYTK) dropped from S&P 600 Health Care	18/03
Cytokinetics to Participate in March Investor Conferences	04/03
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	01/03
Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day	29/02
Cytokinetics, The Mended Hearts, Inc. and WomenHeart Announce Launch of New Initiative to Increase Engagement in Cardiovascular Clinical Trials	28/02
Cytokinetics Q4 Net Loss Narrows, Revenue Decreases; 2024 Outlook Issued	27/02

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Cytokinetics, Incorporated

Azioni

CYTK

US23282W6057

Altre lingue

Filtri